Sponsor:
Taiho Oncology, Inc.
Code:
NCT04256317
Conditions
Myelodysplastic Syndromes
Acute Myeloid Leukemia
Myelodysplastic Syndrome/Neoplasm
Chronic Myelomonocytic Leukemia
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Azacitidine
ASTX030 (cedazuridine + azacitidine)
Azacitidine
ASTX030 (cedazuridine + azacitidine)
Cedazuridine
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-16. This information was provided to ClinicalTrials.gov by Taiho Oncology, Inc. on 2025-05-02.